14-day Premium Trial Subscription Try For FreeTry Free
$1.42
-0.0100 (-0.699%)
At Close: May 17, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

MediciNova Enters into US$20 Million Securities Purchase Agreement with a fund managed by 3D Investment Partners

 09:30pm, Monday, 11'th Jan 2021
LA JOLLA, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Co

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS

 06:30am, Tuesday, 29'th Dec 2020
LA JOLLA, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Co

MediciNova Added to the NASDAQ Biotechnology Index

 06:30am, Tuesday, 15'th Dec 2020
LA JOLLA, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Co

MediciNova Announces Positive Optical Coherence Tomography Results from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS Published in Multiple Sclerosis Journal

 06:30am, Wednesday, 25'th Nov 2020
LA JOLLA, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Co

MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™ 2020

 10:00pm, Thursday, 12'th Nov 2020
LA JOLLA, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Co

Marinus Epilepsy Study, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:MRNS)

 09:57am, Monday, 28'th Sep 2020
Marinus Pharmaceuticals provides updates for pivotal epilepsy study. MediciNova reports data from MN-166 trial for peripheral neuropathy.

The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma

 12:00am, Wednesday, 23'rd Sep 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Arena Pharmaceuticals, Inc...

Coronavirus Vaccine Roundup, Early September

 07:39am, Friday, 04'th Sep 2020
Taking a looking at the COVID-19 vaccine development landscape across various classes, including viral vectors, genetic vaccines, recombinant protein vaccines, attenuated virus vaccines, inactivated v

The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs

 12:00am, Wednesday, 19'th Aug 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) Avenue Therapeutics Inc (NASDAQ: ATXI) Checkmate Pharmaceuticals Inc (NASDAQ: CMPI) DarioHealth Corp (NASDAQ:...

MediciNova Announces the Presentation of Positive Results from Phase 2 Trial of MN‑166 (ibudilast) in Alcohol Use Disorder at the American Psychological Association 2020 Annual Convention

 10:30am, Thursday, 06'th Aug 2020
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:

MediciNova Announces the Presentation of Positive Results from Phase 2 Trial of MN‑166 (ibudilast) in Alcohol Use Disorder at the American Psychological Association 2020 Annual Convention

 10:30am, Thursday, 06'th Aug 2020
LA JOLLA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange�

MNOV: Developing SARS-CoV-2 Vaccine Based on Parainfluenza Virus Vector…

 11:40am, Tuesday, 04'th Aug 2020
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update Licenses SARS-CoV-2 Vaccine On July 27, 2020, MediciNova, Inc. (NASDAQ:MNOV) announced the company entered into a joi

MediciNova to Participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference

 10:30am, Tuesday, 04'th Aug 2020
LA JOLLA, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Co

MediciNova (NASDAQ:MNOV) Earns “Buy” Rating from B. Riley

 03:14am, Tuesday, 04'th Aug 2020
MediciNova (NASDAQ:MNOV)‘s stock had its “buy” rating reiterated by equities researchers at B. Riley in a research report issued to clients and investors on Monday, TipRanks reports. They curren

The Daily Biotech Pulse: Spectrum's Positive Dementia Readout, Pfizer, BioNTech Start Late-Stage Coronavirus Trial, resTORbio Receives COVID-19 Funding

 12:13pm, Tuesday, 28'th Jul 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) * Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) * Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO) * Fulgent Genetics
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE